0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

Invited Commentary on Vasudevan, et al: Outcomes of children with well differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731

Published: Reading: 1 min

Topic overview

This commentary addresses efforts to reduce cisplatin-based chemotherapy in children with well-differentiated fetal hepatoblastoma, given that 25-90% of cisplatin-treated patients develop hearing loss. Identifying candidates for surgery-only treatment could maintain survival while eliminating chronic ototoxicity.

Keywords

Hepatoblastoma Pediatric Oncology Cisplatin Ototoxicity Chemotherapy Reduction Well Differentiated Fetal Surgery Only Treatment Long-term Toxicity

Hashtags

#Hepatoblastoma #PediatricOncology #CisplatinToxicity #ChemotherapyReduction

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. Invited Commentary on Vasudevan, et al: Outcomes of children with well differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. GlobalCastMD Medical Library. 2022-06-16. https://library.globalcastmd.com/article/5500

Comments

Loading comments...